Zenas BioPharma

Zenas BioPharma is advancing global clinical trials for obexelimab to treat autoimmune diseases.

ZB022 is an investigational TYK2-JH2 inhibitor in development for neuroinflammatory and neurodegenerative diseases.

Obexelimab, an investigational drug, is a bifunctional monoclonal antibody engineered to mimic the natural antigen-antibody complex for inhibiting B cells.

Orelabrutinib is an investigational BTK inhibitor in development for progressive multiple sclerosis and other autoimmune diseases.

Zenas BioPharma appointed Hua Mu, MD, Ph.D., as President and CEO, and Joe Farmer as Chief Business Officer.

Zenas BioPharma raised financing led by SR One, NEA, Norwest Venture Partners, and Delos Capital to support clinical development of obexelimab.

Zenas BioPharma named Mr. Oliveira as an executive with commercial experience in biopharmaceuticals.

Zenas BioPharma provides comprehensive employee benefits to support team well-being.

All qualified applicants will receive consideration for employment without discrimination on the basis of race, color, religion, creed, sex, sexual orientation, pregnancy or pregnancy-related conditions, gender identity, genetic information, marital status, familial status, national origin, ancestry, ethnicity, protected veteran status, age, disability or any other factors prohibited by law.

Zenas BioPharma is committed to being a leader in the development and commercialization of transformative immunology-based therapies.

Corporate Headquarters 852 Winter Street Suite 250 Waltham, MA 02451 Get In Touch For investor- or media-related inquiries, please email IR@zenasbio.com

Enabling patients with autoimmune diseases to reimagine life

Last updated: November 14, 2025 This Policy supplements Zenas Privacy Policy and applies to personal information defined as “Consumer Health Data” under applicable state laws governing consumer health data, including, but not limited to, the Washington State My Health My Data Act and the Nevada State Consumer Health Privacy Law (collectively, “Consumer Health Data Laws”). […]

Zenas BioPharma’s Data Privacy Framework Policy outlines privacy principles for personal data from the European Economic Area, Switzerland, and the United Kingdom.

Zenas BioPharma’s Privacy Policy covers its websites and services, emphasizing data security and user privacy.